✦ LIBER ✦

Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab

✍ Scribed by B. Bonnekoh; M. Schulz; I. Franke; H. Gollnick

Publisher: Springer-Verlag
Year: 2002
Tongue: English
Weight: 214 KB
Volume: 128
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-001-0313-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction of tumor burden and stabilizat

Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma

✍ Lucie M. Heinzerling; Margarete Urbanek; Jens O. Funk; Stefan Peker; Oliver Blec 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

Experimental treatment of human diffuse

Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab

✍ Franck Assayag; Nicole Brousse; Jérôme Couturier; Elizabeth Macintyre; Claire Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views

Quality of life during maintenance thera

Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin’s lymphoma: results of a prospective randomized controlled trial

✍ Mathias Witzens-Harig; Monika Reiz; Christiane Heiß; Axel Benner; Manfred Hensel 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 139 KB